Neil Mark D'souza, Radiology - Radiation Oncology Medicare: Medicare Enrolled Practice Location: 13555 W Mcdowell Rd Ste 105&206, Goodyear, AZ 85395 Phone: 623-487-4822 Fax: 623-334-9881 |
Herbert Hitchon, DO Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 13555 W Mcdowell Rd, Suite 105, Goodyear, AZ 85395 Phone: 623-512-4400 Fax: 623-512-4405 |
Dr. Baiywo Rop, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 13169 W Sheridan St, Goodyear, AZ 85395 Phone: 573-823-6273 |
Anjaly B Curley, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 13657 W Mcdowell Rd, Suite 111, Simonmed Imaging, Goodyear, AZ 85395 Phone: 623-302-7930 |
News Archive
Huntington's disease (HD) is characterized by ongoing destruction of specific neurons within the brain. It affects a person's ability to walk, talk, and think - leading to involuntary movement and loss of muscle co-ordination. New research published in BioMed Central's open access journal Molecular Neurodegeneration shows that the RyanR inhibitor Dantrolene is able to reduce the severity of walking and balance problems in a mouse model of HD.
The study, published in the pre-print server medRxiv, demonstrates the presence of long-lasting neuropsychological sequelae after COVID-19, regardless of the respiratory disease's severity.
With the ink hardly dry on the deal providing short-term funding to reopen the government and to raise the debt ceiling, negotiators dived into the next round of fiscal talks. Media reports cast doubt on the possibility of a grand bargain, while Medpage Today suggests the latest deal muddled the prospects for an SGR fix.
VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.
› Verified 9 days ago